Article Text

PDF
Etretinate (tigason) for skin disease

Abstract

Etretinate (Tigason - Roche), an orally active synthetic derivative of Vitamin A, is now marketed for congenital disorders of keratinisation and severe psoriasis. However, because it is potentially hazardous, it is only available-through hospital pharmacies.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.